Nemaura develops medical grade diabetes management app

Nemaura Medical (OTC:NMRD) said today that it has finished development of a medical grade app designed to be used with the company’s SugarBeat continuous glucose monitoring system or with glucose meters.

The mobile app, which was developed for android mobile devices, allows users to input their diet, medication and exercise information, as well as view glucose trends.

Get the full story at our sister site, Drug Delivery Business News.

The post Nemaura develops medical grade diabetes management app appeared first on MassDevice.

from MassDevice http://ift.tt/2xuZfoJ